News GSK and Propeller prepare to launch digital inhaler Deal expands to a commercialisation partnership to prepare for US and Europe marketing.
News Verona pushes on with COPD drug after £70m fundraiser UK biotech hopes RPL554 could be a disease modifying drug.
News After Hikma and Mylan fail, Sandoz files Advair generic in U... FDA accepts Sandoz filing for Advair Diskus generic.
News FDA rejects Sunovion's nebulised COPD drug The US regulator has rejected Sunovion’s nebulised therapy for chronic obstructive pulmonary disease (COPD), leaving the company struggling to stay ahead of rivals.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
